COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will lead to approvals so that there is a vaccine for children in the country by September-October.
In an interview with ANI, Dr Guleria said that Covaxin's data for children after completion of phase two or three trials is expected by September-October.
Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with ICMR. "Children usually have the mild disease but we need to develop vaccines for children because if we have to control this pandemic everyone should be vaccinated.